12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: role of thromboxane and purinergic receptors

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Uridine adenosine tetraphosphate (Up 4A), a novel endothelium-derived vasoactive agent, is proposed to play a role in cardiovascular disorders and induces aortic contraction through activation of cyclooxygenases (COX). We and others demonstrated that activation of A 1 or A 3 adenosine receptors (AR) results in vascular contraction via thromboxane (TX) A 2 production. However, the mechanisms of Up 4A-induced vascular contraction in mouse aorta are not understood. We hypothesize that Up 4A-induced aortic contraction is through COX-derived TXA 2 production, which requires activation of A 1 and/or A 3AR. Concentration responses to Up 4A were conducted in isolated aorta. The TXB 2 production, a metabolite of TXA 2, was also measured. Up 4A (10 −9–10 −5 M) produced a concentration-dependent contraction >70%, which was markedly attenuated by COX and COX1 but not by COX2 inhibition. Notably, Up 4A-induced aortic contraction was blunted by both TX synthase inhibitor ozagrel and TXA 2 receptor (TP) antagonist SQ29548. Surprisingly, A 3AR deletion had no effect on Up 4A-induced contraction. Moreover, A 1AR deletion or antagonism as well as A 1/A 3AR deletion potentiated Up 4A-induced aortic contraction, suggesting a vasodilator influence of A 1AR. In contrast, non-selective purinergic P2 receptor antagonist PPADS significantly blunted Up 4A-induced aortic contraction to a similar extent as selective P2X 1R antagonist MRS2159, the latter of which was further reduced by addition of ozagrel. Endothelial denudation almost fully attenuated Up 4A-induced contraction. Furthermore, Up 4A (3 µM) increased TXB 2 formation, which was inhibited by either MRS2159 or ozagrel. In conclusion, Up 4A-induced aortic contraction depends on activation of TX synthase and TP, which partially requires the activation of P2X 1R but not A 1 or A 3 AR through an endothelium-dependent mechanism.

          Graphical Abstract

          Related collections

          Author and article information

          Journal
          101130615
          29859
          Vascul Pharmacol
          Vascul. Pharmacol.
          Vascular pharmacology
          1537-1891
          1879-3649
          6 May 2015
          25 April 2015
          October 2015
          01 October 2016
          : 73
          : 78-85
          Affiliations
          [a ]Department of Physiology and Pharmacology, Center for Cardiovascular and Respiratory Sciences, Clinical and Translational Science Institute, West Virginia University, Morgantown, WV, USA
          [b ]Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
          Author notes
          [* ]Corresponding author: S. Jamal Mustafa, Ph.D., Department of Physiology and Pharmacology, West Virginia University, PO Box 9104, Morgantown, WV 26506-9104, Tel: +1-304-2935830, Fax: +1-304-2937038, sjmustafa@ 123456hsc.wvu.edu
          Article
          PMC4578990 PMC4578990 4578990 nihpa684822
          10.1016/j.vph.2015.04.009
          4578990
          25921923
          6a7b7afc-5999-49cb-bc00-6f46e5e30e74
          History
          Categories
          Article

          vasoconstriction,endothelium,thromboxane,P2X1 ,mouse aorta,Up4A
          vasoconstriction, endothelium, thromboxane, P2X1 , mouse aorta, Up4A

          Comments

          Comment on this article